PTEN and neoplasm: Indeed, tumors lacking PTEN have been associated with an immunologically “cold” TIME, harboring fewer TILs and more immunosuppressive and pro-tumorigenic myeloid and lymphoid cells which can negatively impact immunotherapy treatment outcomes.24–26 These observations suggest that the loss of PTEN may influence how tumor cells communicate with their immediate environment.